Profile data is unavailable for this security.
About the company
MedPlus Health Services Limited is an India-based company. The Company is primarily engaged in retail trading of medicines and general items, wholesale cash and carry and pathological laboratory testing services, wholesale trading and manufacturing of pharmaceutical products, fast-moving consumer goods and beauty products. It operates through three segments: Retail, Diagnostics, and Others. The Retail segment is engaged in trading of pharmaceuticals and general items through its retail stores and online platform. The Diagnostics segment includes diagnostic services, pathological services, and laboratory testing services. The Other segment includes insurance broking business. The Company operates approximately 4,712 stores. Its omni-channel platform enables the Company to service its customers through its stores, as well as its online channels. Its e-commerce portals include MedPlus Mart, MedPlus Lens, and MedPlus Labs.
- Revenue in INR (TTM)65.38bn
- Net income in INR2.07bn
- Incorporated2006
- Employees25.00k
- LocationMedPlus Health Services Ltd5-9-13 707 7Th FloorTaramandal Commercial Com, SaifabadHYDERABAD 500037IndiaIND
- Phone+91 4 067006700
- Websitehttps://www.medplusindia.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sipai Health Technology Co, Ltd | 44.56bn | -4.13bn | 20.94bn | 2.95k | -- | 1.64 | -- | 0.4699 | -0.5682 | -0.5682 | 6.18 | 1.49 | 1.44 | 14.81 | 7.29 | 1,187,379.00 | -15.51 | -52.80 | -28.98 | -79.72 | 9.74 | 8.16 | -10.75 | -34.60 | 1.67 | -- | 0.0252 | -- | -3.11 | 34.45 | -26.57 | -- | -8.64 | -- |
| Fangzhou Inc | 37.44bn | -308.00m | 40.83bn | 485.00 | -- | 20.25 | -- | 1.09 | -0.0198 | -0.0198 | 2.43 | 0.126 | 4.29 | 13.75 | 74.78 | 6,637,565.00 | -3.53 | -- | -22.44 | -- | 18.02 | -- | -0.8227 | -- | 0.8734 | 0.1636 | 0.1956 | -- | 11.22 | -- | -334.42 | -- | -- | -- |
| JZJ Chain Drugstore Corp | 118.42bn | 1.66bn | 41.24bn | 17.63k | 24.68 | 1.21 | -- | 0.3483 | 0.8305 | 0.8305 | 59.09 | 16.99 | 0.8898 | 2.10 | 15.58 | 516,114.80 | 1.27 | 4.24 | 2.67 | 8.13 | 35.31 | 35.31 | 1.43 | 4.12 | 0.3453 | 2.20 | 0.6304 | 48.72 | 2.23 | 21.34 | -69.08 | -5.29 | 15.00 | -- |
| Genky DrugStores Co Ltd | 121.52bn | 4.50bn | 79.72bn | 1.84k | 17.44 | 2.36 | 9.55 | 0.6561 | 256.34 | 256.34 | 6,928.04 | 1,891.26 | 1.66 | 6.05 | 47.17 | 114,768,600.00 | 6.15 | 5.34 | 9.42 | 8.48 | 20.47 | 20.47 | 3.70 | 3.22 | 0.2809 | 48.77 | 0.3793 | 6.99 | 8.62 | 10.19 | 11.73 | 20.73 | 6.54 | 0.7875 |
| MedPlus Health Services Ltd | 65.38bn | 2.07bn | 103.58bn | 25.00k | 50.04 | -- | 21.63 | 1.58 | 17.25 | 17.25 | 544.80 | -- | -- | -- | -- | 2,615,076.00 | -- | 3.44 | -- | 4.32 | 26.24 | 22.31 | 3.17 | 1.83 | -- | 2.67 | -- | 0.00 | 9.09 | 16.41 | 129.59 | 133.19 | 14.50 | -- |
| Dashenlin Pharmaceutical Group Co Ltd | 349.32bn | 14.81bn | 295.02bn | 43.53k | 19.88 | 3.13 | -- | 0.8446 | 1.00 | 1.00 | 23.86 | 6.35 | 1.03 | 4.28 | 22.02 | 616,415.10 | 4.72 | 5.62 | 10.67 | 11.14 | 33.97 | 36.48 | 4.57 | 5.00 | 0.6584 | 12.56 | 0.4131 | 51.24 | 8.01 | 18.92 | -21.58 | 5.42 | 24.10 | 16.46 |
| Yifeng Pharmacy Chain Co Ltd | 314.11bn | 21.38bn | 400.40bn | 40.02k | 19.08 | 2.75 | -- | 1.27 | 1.33 | 1.33 | 19.54 | 9.22 | 0.9057 | 3.51 | 15.33 | 602,957.60 | 6.66 | 6.75 | 12.23 | 12.46 | 39.73 | 38.98 | 7.36 | 6.83 | 1.01 | 67.62 | 0.2836 | 28.44 | 6.53 | 18.55 | 8.26 | 22.96 | 8.50 | 45.96 |
| Holder | Shares | % Held |
|---|---|---|
| Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 Dec 2025 | 9.12m | 7.61% |
| Franklin Templeton Asset Management (India) Pvt Ltd.as of 31 Dec 2025 | 4.11m | 3.43% |
| Kotak Mahindra Asset Management Co. Ltd.as of 31 Dec 2025 | 3.97m | 3.32% |
| SBI Funds Management Ltd.as of 19 Nov 2024 | 2.98m | 2.48% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 2.83m | 2.36% |
| FIL Investment Management (Singapore) Ltd.as of 30 Nov 2025 | 1.79m | 1.49% |
| Goldman Sachs Asset Management LPas of 09 Jan 2026 | 1.57m | 1.31% |
| Invesco Asset Management (India) Pvt Ltd.as of 31 Dec 2025 | 1.09m | 0.91% |
| ICICI Prudential Asset Management Co. Ltd. (Invt Mgmt)as of 31 Dec 2025 | 1.07m | 0.90% |
| BlackRock Fund Advisorsas of 09 Jan 2026 | 897.88k | 0.75% |
